ReviewThe Journal of investigative dermatology2021

Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.

Joachim G S Veit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.